Related Experiment Video
Updated: Apr 2, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
SHAP-explained machine-learning model for high-risk gastric cancer identification.
Hyun Jin Oh1, Chung Ho Kim2, Jae Kwan Jun3
1Division of Gastroenterology, Department of Internal Medicine, Center for Cancer Prevention and Detection, National Cancer Center, Goyang, Republic of Korea.
A new machine learning model accurately predicts 2-year gastric cancer risk using Helicobacter pylori status and endoscopic findings like atrophic gastritis. This tool aids in risk-adapted screening for better public health outcomes in Asia.
Area of Science:
- Gastroenterology
- Oncology
- Data Science
Background:
- Gastric cancer (GC) is a significant health issue, particularly in Asia.
- Effective screening strategies are needed, considering regional factors like Helicobacter pylori (H. pylori) infection and precancerous lesions such as atrophic gastritis (AG) and intestinal metaplasia (IM).
Purpose of the Study:
- To develop and validate a short-term (2-year) gastric cancer risk prediction model.
- To integrate endoscopic findings (AG/IM) with demographic and lifestyle factors for improved risk assessment.
- To compare the performance of machine learning models against conventional methods.
Main Methods:
- Utilized a large, real-world, nationwide screening cohort with AG/IM endoscopic codes.
- Developed and compared risk prediction models using Cox proportional hazards model (CPHM), extreme gradient boosting (XGBoost), decision tree (DT), and logistic regression (LR).
- Evaluated model performance through internal and external validation, assessing discrimination and calibration. Employed Shapley Additive Explanations (SHAP) for model interpretability.
Main Results:
- The XGBoost model exhibited superior performance in both internal (AUROC 0.764) and external (AUROC 0.708) validation.
- SHAP analysis identified H. pylori infection, age, sex, smoking, and AG/IM as key predictors of gastric cancer risk.
- The model demonstrated good discrimination and calibration, highlighting its potential clinical utility.
Conclusions:
- An interpretable, externally validated 2-year GC risk model incorporating AG/IM findings offers a practical tool for risk-adapted screening.
- This model can identify high-risk individuals for targeted surveillance and clinical review.
- Understanding the key contributing factors through SHAP enhances the model's transparency and clinical applicability.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025